GJA1 and hematopoietic and lymphoid system neoplasm: The study of BMSCs from patients with blood cancer and healthy individuals reveals differences in morphology, differentiation capacity, and growth rate of BMSCs, in addition to that, we 25 and others 61 show the altered GJIC functions in BMSCs generated from AML patients, including the decrease in GJIC-Cx43 protein.